eHIV Review

Despite the uncertainty created by current changes in research funding, the quest to end HIV/AIDS as a public health threat continues. And as it has for the past 33 years, CROI (the Conference on Retroviruses and Opportunistic Infections) continues to be one of the most important gatherings of clinicians, scientists, and researchers. 

It's critical that clinicians who treat people with HIV or at risk for HIV understand the new data about the rapidly changing HIV treatment landscape: the results of trials to simplify treatment; investigations into longer-acting injectable and oral medications; ongoing explorations into how HIV can influence CVD and hyperlipidemia treatments; and novel ways to successfully expand PrEP uptake. 

To explain ways to integrate these advances into clinical practice, we’ve called on one of our long-time Program Directors — Ethel D. Weld, MD, PhD, from the Division of Infectious Diseases at the Johns Hopkins University School of Medicine — to guest author this issue of eHIV Review.